Mostrar el registro sencillo del ítem

dc.contributor.author
Puricelli, Lydia Ines  
dc.contributor.author
Bal, Elisa Dora  
dc.contributor.author
Eiján, Ana María  
dc.contributor.author
Entín, Daniel  
dc.contributor.author
Sacerdote de Lustig, Eugenia  
dc.date.available
2021-01-13T19:37:57Z  
dc.date.issued
1985-11  
dc.identifier.citation
Puricelli, Lydia Ines; Bal, Elisa Dora; Eiján, Ana María; Entín, Daniel; Sacerdote de Lustig, Eugenia; Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability; Elsevier; Cancer Letters; 29; 2; 11-1985; 189-195  
dc.identifier.issn
0304-3835  
dc.identifier.uri
http://hdl.handle.net/11336/122644  
dc.description.abstract
The levels of fibronectin (FN) were assayed in plasma of mice subcutaneously inoculated with a mammary adenocarcinoma of moderate metastatic ability (M3) and a related variant tumor with higher metastasizing potential (MM3). The mean plasmatic FN concentration increased in parallel with increased M3 and MM3 size and weight. Highest and earliest FN increases were observed in mice inoculated with the rapidly growing M3 tumor. A strong correlation between the level of plasma fibronectin and the number of lung metastases was only found in MM3 inoculated mice. Plasma fibronectin level is a good biological marker of tumoral growth rate in these adenocarcinoma tumors, but its role in the metastatic process warrants investigation.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
FIBRONECTIN  
dc.subject
ADENOCARCINOMA  
dc.subject
SACERDOTE INVESTIGADORA  
dc.subject
PUBLICACIONES  
dc.subject.classification
Oncología  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Levels of plasmatic fibronectin in mice bearing adenocarcinomas of different metastasizing ability  
dc.type
info:eu-repo/semantics/article  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.journal.volume
29  
dc.journal.number
2  
dc.journal.pagination
189-195  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Puricelli, Lydia Ines. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Bal, Elisa Dora. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Eiján, Ana María. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina  
dc.description.fil
Fil: Entín, Daniel. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina  
dc.description.fil
Fil: Sacerdote de Lustig, Eugenia. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.journal.title
Cancer Letters  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/0304383585901582  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/0304-3835(85)90158-2  
dc.provenance
Otro  
dc.format.espacioDeColor
EscalaGris  
dc.format.compresion
No especifica  
dc.description.nivelDescripcion
Unidad documental simple  
dc.type.subtype
Artículo científico  
dc.type
info:ar-repo/semantics/artículo